- Home
- MAIA vs GNSS Comparison
MAIA vs GNSS Comparison
Compare MAIA & GNSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- GNSS
- Stock Information
- Founded
- MAIA 2018
- GNSS 1992
- Country
- MAIA United States
- GNSS United States
- Employees
- MAIA N/A
- GNSS N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- GNSS Consumer Electronics/Appliances
- Sector
- MAIA Health Care
- GNSS Consumer Staples
- Exchange
- MAIA Nasdaq
- GNSS Nasdaq
- Market Cap
- MAIA 62.4M
- GNSS 169.5M
- IPO Year
- MAIA 2022
- GNSS N/A
- Fundamental
- Price
- MAIA $2.82
- GNSS $3.75
- Analyst Decision
- MAIA
- GNSS Strong Buy
- Analyst Count
- MAIA 0
- GNSS 3
- Target Price
- MAIA N/A
- GNSS $5.08
- AVG Volume (30 Days)
- MAIA 60.0K
- GNSS 106.7K
- Earning Date
- MAIA 11-05-2024
- GNSS 12-05-2024
- Dividend Yield
- MAIA N/A
- GNSS N/A
- EPS Growth
- MAIA N/A
- GNSS N/A
- EPS
- MAIA N/A
- GNSS N/A
- Revenue
- MAIA N/A
- GNSS $27,968,000.00
- Revenue This Year
- MAIA N/A
- GNSS N/A
- Revenue Next Year
- MAIA N/A
- GNSS $138.10
- P/E Ratio
- MAIA N/A
- GNSS N/A
- Revenue Growth
- MAIA N/A
- GNSS N/A
- 52 Week Low
- MAIA $0.82
- GNSS $1.51
- 52 Week High
- MAIA $5.99
- GNSS $4.04
- Technical
- Relative Strength Index (RSI)
- MAIA 50.98
- GNSS 60.29
- Support Level
- MAIA $2.36
- GNSS $3.67
- Resistance Level
- MAIA $2.72
- GNSS $3.94
- Average True Range (ATR)
- MAIA 0.22
- GNSS 0.14
- MACD
- MAIA 0.02
- GNSS -0.02
- Stochastic Oscillator
- MAIA 72.28
- GNSS 77.78
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About GNSS Genasys Inc.
Genasys Inc is a provider of critical communications solutions designed to help keep people safe. The company is engaged in the design, development, and commercialization of directed and multidirectional sound technologies, voice broadcast products and location-based mass messaging solutions for emergency warning and workforce management. Its operating segment includes Hardware and Software. The company generates maximum revenue from the Hardware segment. Geographically, it derives a majority of revenue from the Americas region and also has its presence in the Asia Pacific and Europe, Middle East and Africa.